诺和诺德终止合作引燃复合药物争议

生物制品圈
Jul 09, 2025

摘要:诺和诺德近期突然终止与数字医疗公司 Hims & Hers 的合作协议,引发行业对复合药物合规性的激烈讨论。此次合作原计划通过 Hims & Hers 的平台提供司美格鲁肽复合制剂,但其终止暴露了制药巨头对复合药物潜在风险的担忧,也凸显了监管模糊地带下的市场博弈。一、合作戛然而止:巨头与数字平台的决裂2025 年 2 月,诺和诺德与 Hims & Hers 宣布达成合作,计划通过后者的线上...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10